Atıf İçin Kopyala
ADIGÜZEL A.
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, cilt.13, ss.11-15, 2022 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
13
-
Basım Tarihi:
2022
-
Doi Numarası:
10.4328/acam.21059
-
Dergi Adı:
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI)
-
Sayfa Sayıları:
ss.11-15
-
Anahtar Kelimeler:
Lacosamide, Antiepileptic Drugs, GFR, Sodium Channel Blocker, Seizure, REFRACTORY EPILEPSY, TOLERABILITY, SAFETY, RISK
-
İnönü Üniversitesi Adresli:
Evet
Özet
Aim: Lacosamide, a third-generation antiepileptic drug, is used as adjunctive treatment of partial-onset seizures. It is mainly eliminated through the kidneys. The drug acts by enhancing the slow inactivation of voltage-gated sodium channels. The aim of this study was to investigate the long-term effects of lacosamide on renal function.